Evidence map›Paper›PMID 28582393›Full record

Trial reportPloS one2017

High correlation between Framingham equations with BMI and with lipids to estimate cardiovascular risks score at baseline in HIV-infected adults in the Temprano trial, ANRS 12136 in Côte d'Ivoire.

Calixte Ghehi, Delphine Gabillard, Raoul Moh, Anani Badje, Gérard Menan Kouamé, Eric Oouttara, Hugues Ahibo, Jean Baptiste N'Takpé, Jérôme Lecarrou, Serge Paul Eholié and 2 more

Open access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Calixte GhehiProgramme PACCI - ANRS research site, Abidjan, Côte d'Ivoire.
Delphine GabillardInserm U1219, Université de Bordeaux, Bordeaux, France.
Raoul MohProgramme PACCI - ANRS research site, Abidjan, Côte d'Ivoire.
Anani BadjeProgramme PACCI - ANRS research site, Abidjan, Côte d'Ivoire.
Gérard Menan KouaméProgramme PACCI - ANRS research site, Abidjan, Côte d'Ivoire.
Eric OouttaraInserm U1219, Université de Bordeaux, Bordeaux, France.
Hugues AhiboCentre de Recherche et Diagnostic sur le SIDA, (Cedres) CHU de Treichville, Abidjan, Côte d'Ivoire.
Jean Baptiste N'TakpéProgramme PACCI - ANRS research site, Abidjan, Côte d'Ivoire.
Jérôme LecarrouInserm U1219, Université de Bordeaux, Bordeaux, France.
Serge Paul EholiéProgramme PACCI - ANRS research site, Abidjan, Côte d'Ivoire.
Xavier AnglaretProgramme PACCI - ANRS research site, Abidjan, Côte d'Ivoire.
Christine DanelProgramme PACCI - ANRS research site, Abidjan, Côte d'Ivoire.
Université de Bordeaux · FRProgramme PAC-CI · CIUniversity Hospital Medical Center at Treichville · CI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextData on cardiovascular risk (CVR) score among HIV-infected patients in sub-Saharan Africa are scarce. Our first objective was to compare the CVR score of Framingham utilizing BMI and lipids at baseline, and secondary to assess evolution of CVR score over time at Month 30 in the Temprano trial.

methodsHIV-infected adults with CD4 <800/mm3 without criteria for initiating ART were included and followed for 30 months in the Temprano trial, which assessed the benefits and risks of early antiretroviral treatment (ART) vs deferred ART. CVR score was estimated at baseline and Month-30 using Framingham equations with either BMI or lipids and classified as high (>20%), moderate (10-20%), and low risk (<10%). At baseline, we compare these two estimations utilizing the Pearson correlation test and analyze the increasing CV risk score over time by Proportional odds cumulative logit models for people attending the Month-30 (M30) visit.

resultsAmong the 2056 patients, 78% were women, median age was 35 years, and median CD4 count was 464/mm3, 6.8% were obese, 6.3% had hypertension, 7.8% were smokers (1.8% women, 26.8% men), 19% had Total Cholesterol (TC) >5mmol/L, and 1% diabetes at baseline. At baseline the concordance between the two Framingham equations was excellent (r = 0.95; p<0.0001). Among the 1700 patients who attended M30 visit and with available data, 1.3% had a high CV risk score at baseline and 3.1% at M30 visit using Framingham equation with BMI. Adjusted odds ratio (aOR) of being at a higher CV risk score at M30 visit compared to a higher CV risk score at M0 visit was 1.35 (CI 95% 1.17-1.57). Stratified by sex, the increasing CV risk score was OR 1.73 (CI 95%: 1.30-2.29) for women and OR 1.24 (CI 95%: 1.02-1.50) for men. Early ART was not associated with an increasing CV risk score (p = 0.88). Results for the 1422 patients with Framingham equation using lipids were similar.

conclusionIn a large trial evaluating early ART for HIV infection in Côte d'Ivoire, Framingham equation with BMI and lipids were highly correlated and CV risk score increases over time. Early ART was not significantly associated with this increasing CV risk score.

Indexed as

AdultAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveBody Mass IndexCardiovascular DiseasesCD4 Lymphocyte CountCholesterol, HDLCholesterol, LDLCote d'IvoireFemaleHIV InfectionsHumansMaleOdds RatioRisk FactorsStatistics, NonparametricAnti-HIV AgentsCholesterol, HDLCholesterol, LDLTriglycerides

Identifiers

PMID28582393
PMCPMC5459337
OpenAlexW2624527174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.